Brief: Captor Therapeutics EGM Resolves On Launching Incentive Programme

Captor Therapeutics SA

25/02/2025 06:59

Feb 25 (Reuters) - Captor Therapeutics SA  CTXP.WA :
    * SAID ON MONDAY ITS EXTRAORDINARY GENERAL MEETING (EGM)
RESOLVED
ON ESTABLISHING AND IMPLEMENTING AN INCENTIVE PROGRAMME AS WELL
AS BUYBACK, WHICH IS LINKED TO IT 
    * THE AIM OF THE INCENTIVE PROGRAMME IS TO ENSURE THE
LONG-TERM
DEVELOPMENT OF THE COMPANY AND TO MAINTAIN A STABLE TEAM
MOTIVATED TO DEVELOP THE COMPANY AND ITS SUBSIDIARIES
    * THE TOTAL NUMBER OF INCENTIVE SHARES ALLOCATED TO ELIGIBLE
PERSONS WILL NOT EXCEED 247,244 OF COMPANY'S ORDINARY SHARES 
    * THE SALE PRICE OR THE ISSUE PRICE OF NEW SHARES UNDER
PROGRAMME
WILL EQUAL 0.10 ZLOTY PER SHARE, WHICH IS A SHARE'S NOMINAL
VALUE
    * BUYBACK OF UP TO 10,000 SHARES WILL BE CARRIED OUT FOR THE
SAKE
OF THE INCENTIVE PROGRAMME
    * COMPANY TO BUY BACK SHARES FREE OF CHARGE 
    * PROVIDING THAT SHARES ACQUIRED UNDER BUYBACK ARE NOT USED
FOR
THE INCENTIVE PROGRAMME WITHIN 5 YEARS FROM THE DATE OF THEIR
ACQUISITION BY THE COMPANY, THEY WILL BE RETURNED FREE OF CHARGE
TO MICHAL WALCZAK (CHIEF SCIENTIFIC OFFICER)

        
 Source text for Workspace:  urn:newsml:reuters.com:*:nEM46V2cxa
 Further company coverage:  CTXP.WA  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))